Abstract
We conducted this research to determine the prevalence rate and presentation patterns with microcystic macular oedema (MMO) in glaucoma patients. The protocol was pre-registered on PROSPERO (CRD42022316367). PubMed, Scopus, Web of Science, EMBASE, ProQuest, EBSCOHost, CENTRAL, clinicaltrials.gov, and Google Scholar were searched for articles reporting MMO in glaucoma patients. The primary outcome was the prevalence of MMO, while secondary outcomes included the comparison between MMO and non-MMO in terms of patients’ characteristics (age, gender), glaucoma stage, and ocular parameters (axial length (AL), intraocular pressure, mean deviation, spherical equivalent). Data are reported as mean difference (MD) or log odds ratio (logOR) along with their corresponding 95% confidence intervals (CI) for continuous and dichotomous outcomes, respectively. The quality of included studies was assessed using the NIH tool, and the certainty of evidence was assessed using GRADE framework. Ten studies (2128 eyes) were included, revealing an overall prevalence rate of MMO of 8% (95%CI: 5–12%). When compared to non-MMO group, MMO was associated with lower age (MD = −5.91; 95%CI: −6.02: −5.20), greater risk of advanced glaucoma stage (LogOR=1.41; 95%CI: 0.72: 2.09), and lower mean deviation of the visual field (MD = −5.00; 95%CI: −7.01: −2.99). No significant difference was noted between both groups in terms of gender, axial length, or spherical equivalent. Three studies had good quality while seven had poor quality. MMO is a prevalent observation in glaucoma patients and is associated with patients’ age and stage of the disease. However, the certainty of evidence remains very low.
摘要
该研究旨在确定青光眼患者中微小黄斑囊性水肿 (microcystic macular oedema, MMO) 的流行率和表现模式。该研究已在PROSPERO进行预注册 (CRD42022316367) 。检索了PubMed, Scopus, Web of Science, EMBASE, ProQuest, EBSCOHost, CENTRAL, clinicaltrials.gov和谷歌学术中报告了青光眼患者MMO的文献。主要结局为MMO的患病率, 次要结局包括MMO和非MMO患者的特征 (年龄, 性别), 青光眼分期和眼部参数 (轴长 (axial length, AL) 、眼压、平均偏差、等效球镜度数) 。对于连续和二分类变量, 数据以平均差 (mean difference, MD) 或对数比值比 (log odds ratio, logOR) 及其95%的置信区间 (confidence intervals, CI) 表示。使用NIH工具评估纳入研究的质量, 使用GRADE框架评估证据的确定性。共纳入了10项研究 (2128只眼), 显示MMO的总患病率为8% (95%CI: 5–12%) 。与非MMO组对比, MMO组与较低的年龄 (MD = −5.91; 95%CI: −6.02: −5.20), 青光眼晚期高风险 (LogOR=1.41; 95%CI: 0.72: 2.09) 以及更低的视野平均偏差 (MD = −5.00; 95%CI: −7.01: −2.99) 相关。两组在性别、轴向长度和等效球镜度数方面无显著差异。纳入的文献中, 有三篇文献的质量较好, 七篇文献质量较差。MMO在青光眼患者中较为常见, 且与患者年龄及青光眼疾病分期密切相关。然而, 目前证据的确定性仍然较低。
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–20.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–7.
Thylefors B, Negrel A. The global impact of glaucoma. Bull World Health Organ. 1994;72:323.
Airaksinen P. Clinical evaluation of the optic disc and retinal nerve fiber layer. Glaucomas. 1996.
Stamper RL, Lieberman MF, Drake MV. Becker-Shaffer’s. Diagnosis and therapy of the glaucomas 7th ed St Louis: Mosby. 1999:15.
Govetto A, Su D, Farajzadeh M, Megerdichian A, Platner E, Ducournau Y, et al. Microcystoid macular changes in association with idiopathic epiretinal membranes in eyes with and without glaucoma: clinical insights. Am J Ophthalmol. 2017;181:156–65.
Kisimbi J, Shalchi Z, Mahroo OA, Mhina C, Sanyiwa AJ, Mabey D, et al. Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy. Brain. 2013;136:3418–26.
Jiramongkolchai K, Freedman SF, El-Dairi MA. Retinal changes in pediatric glaucoma and nonglaucomatous optic atrophy. Am J Ophthalmol. 2016;161:188–95.e1.
Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012;135:1786–93.
Bhatti MT, Mansukhani SA, Chen JJ. Microcystic macular edema in optic nerve glioma. Ophthalmology. 2020;127:930.
Voide N, Borruat FX. Microcystic macular edema in optic nerve atrophy: a case series. Klin Monatsblatter Augenheilkunde. 2015;232:455–8.
Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M. Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology. 2014;121:142–9.
Burggraaff MC, Trieu J, de Vries-Knoppert WA, Balk L, Petzold A. The clinical spectrum of microcystic macular edema. Investig Ophthalmol Visual Sci. 2014;55:952–61.
Wen JC, Freedman SF, El-Dairi MA, Asrani S. Microcystic macular changes in primary open-angle glaucoma. J Glaucoma. 2016;25:258–62.
Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. Müller cells as players in retinal degeneration and edema. Graefe’s Arch Clin Exp Ophthalmol. 2007;245:627–36.
Hasegawa T, Akagi T, Yoshikawa M, Suda K, Yamada H, Kimura Y, et al. Microcystic inner nuclear layer changes and retinal nerve fiber layer defects in eyes with glaucoma. PloS One. 2015;10:e0130175.
Wolff B, Azar G, Vasseur V, Sahel JA, Vignal C, Mauget-Faÿsse M. Microcystic changes in the retinal internal nuclear layer associated with optic atrophy: a prospective study. J Ophthalmol. 2014;2014:395189.
Wolff B, Basdekidou C, Vasseur V, Mauget-Faÿsse M, Sahel J-A, Vignal C. Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina. 2013;33:2133–8.
Hasegawa T, Ooto S, Takayama K, Makiyama Y, Akagi T, Ikeda HO, et al. Cone integrity in glaucoma: an adaptive-optics scanning laser ophthalmoscopy study. Am J Ophthalmol. 2016;171:53–66.
Murata N, Togano T, Miyamoto D, Ochiai S, Fukuchi T. Clinical evaluation of microcystic macular edema in patients with glaucoma. Eye. 2016;30:1502–8.
Mahmoudinezhad G, Salazar D, Morales E, Tran P, Lee J, Hubschman JP, et al. Risk factors for microcystic macular oedema in glaucoma. Br J Ophthalmol. 2021.
Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22:128.
Muka T, Glisic M, Milic J, Verhoog S, Bohlius J, Bramer W, et al. A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research. Eur J Epidemiol. 2020;35:49–60.
Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020;37:387.
Ghozy S, Kacimi SEO, Azzam AY, Farahat RA, Abdelaal A, Kallmes KM, et al. Successful mechanical thrombectomy in acute ischemic stroke: revascularization grade and functional independence. J NeuroInterv Surg. 2022;14:779–82.
National Heart L, Institute B. National Institute of Health, Quality assessment tool for observational cohort and cross-sectional studies. Bethesda: National Heart. Lung, and Blood Institute. 2014.
Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:1–10.
Fisher DJ, Zwahlen M, Egger M, Higgins JP. Meta‐analysis in stata. systematic reviews in health research: meta‐analysis in context. 2022;22:481–509.
Abdellatif M, Ghozy S, Kamel MG, Elawady SS, Ghorab MME, Attia AW, et al. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Eur J Pediatr. 2019;178:301–14.
Brazerol J, Iliev ME, Höhn R, Fränkl S, Grabe H, Abegg M. Retrograde maculopathy in patients with glaucoma. J Glaucoma. 2017;26:423–9.
El Maftouhi A, Quaranta-El Maftouhi M, Baudouin C, Denoyer A. Cystic maculopathy of the inner nuclear layer in glaucoma patients. J Francais d’Ophtalmol. 2021;44:786–91.
Querques G, Coscas F, Forte R, Massamba N, Sterkers M, Souied EH. Cystoid macular degeneration in exudative age-related macular degeneration. Am J Ophthalmol. 2011;152:100–7. e2.
Leung CK, Ye C, Weinreb RN, Yu M, Lai G, Lam DS. Impact of age-related change of retinal nerve fiber layer and macular thicknesses on evaluation of glaucoma progression. Ophthalmology. 2013;120:2485–92.
Author information
Authors and Affiliations
Contributions
AA: conceptualisation of the research idea, protocol registration, idea validation, data checking, data analysis, manuscript writing, and revision and approval of the final version of the manuscript; MMO: conceptualisation of the research idea, protocol registration, idea validation, data checking, manuscript writing, and revision and approval of the final version of the manuscript; BA: conceptualisation of the research idea, formulating the search query for each database, carrying out the database search, substantial editing and revision of the manuscript, and approval of the final version of the manuscript; BEK, HB, and RAF: screening of retrieved records, extraction of data for analysis, quality assessment, and approval of the final manuscript; HAS: substantial contribution to the writing of the manuscript as well as editing for the improvement of the quality of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abdelaal, A., Eltaras, M.M., Katamesh, B.E. et al. The prevalence and presentation patterns of microcystic macular oedema: a systematic review and meta-analysis of 2128 glaucomatous eyes. Eye 37, 3322–3333 (2023). https://doi.org/10.1038/s41433-023-02524-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02524-w